Hudson Bay Capital Management
CELZ icon

Hudson Bay Capital Management’s Creative Medical Technology CELZ Stock Holding History

Hudson Bay Capital Management’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Buy
+135,170
New +$292K ﹤0.01% 1114
2022
Q1 		– Sell
-8,000
Closed -$177K – 1211
2021
Q4 		$177K Buy
+8,000
New +$168K ﹤0.01% 915

Other funds holding CELZ

AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hudson Bay Capital Management's CELZ Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Creative Medical Technology (CELZ) in Q2 2026: 135,170 shares worth $196K. The stake represents ﹤0.01% of the portfolio and ranks #1114 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in CELZ as recently as Q4 2021.

Hudson Bay Capital Management first reported a position in CELZ in Q4 2021 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold CELZ as of Q2 2026.

  • Hudson Bay Capital Management held 135,170 shares of Creative Medical Technology worth $196K as of Q2 2026.
  • Creative Medical Technology was a new Hudson Bay Capital Management position in Q2 2026.
  • Creative Medical Technology made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #1114 holding.
  • Hudson Bay Capital Management first reported a position in Creative Medical Technology in Q4 2021 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.